生物科技的跨國變革：從抗肥胖藥物合作到逆轉老化研究 | Biotech’s Cross-Border Evolution: From GLP-1 Partnerships to Age-Reversal Research

The biotech industry is seeing increased cross-border collaboration, with progress in GLP-1 obesity treatments and innovations in cellular reprogramming and drug delivery driving global advancements in medical science.